Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes

Abstract Background Anti-vascular endothelial growth factor (anti-VEGF) therapy is used for myopic choroidal neovascularization (mCNV). Patchy chorioretinal atrophy (pCRA) enlargement has been reported in mCNV cases associated with vision loss. Our aim was to compare the long-term effectiveness of a...

Descrición completa

Detalles Bibliográficos

Principais autores:	Meng-Tian Kang, Ningli Wang, Wenjun Xu, Mayinuer Yusufu, Wu Liu, Jiaxin Tian, Yue Qi
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2024-03-01
Series:	BMC Ophthalmology
Assuntos:	Choroidal neovascularization Myopic maculopathy Anti-vascular endothelial growth factor Posterior scleral reinforcement
Acceso en liña:	https://doi.org/10.1186/s12886-024-03357-1
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!